Publications
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Elevated D-dimer as an immediate response to alemtuzumab treatment2021 | Second Faculty of Medicine
- Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients2020 | Second Faculty of Medicine
- Epidemiology, clinical manifestation, and disease course of neuromyelitis optica spectrum disorders2020 | Second Faculty of Medicine
- Interferons-β treatment during pregnancy and breast-feeding2020 | Second Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Biomarkers of disease course and prognosis in multiple sclerosis patients2018 | Second Faculty of Medicine
Loading network view...